DNA Script and leading healthcare solutions provider awarded up to $26M by ARPA-H to advance cell-free DNA bioproduction

FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies

Qureight closes $20 million Series B financing

Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension Investment will support Qureight’s next-generation AI-powered quantitative imaging platform to further accelerate clinica

Leerink Partners Report Names Carterra a Core Enabler of the $7B "Lab-in-the-Loop" Antibody Discovery Market

New research on AI-driven biologics discovery identifies Carterra's high-throughput SPR platforms as central to the Lab-in-the-Loop (LitL) workflow reshaping drug discovery, with Twist Bioscience and Adaptyv Bio pointing to surging demand for Carterra technology

SynGenSys makes key appointments to strengthen senior commercial and scientific teams

· Heads of Commercial, CHO Expression Technologies, Cell and Gene Therapy Expression Technologies, and Bioinformatics and Data Science appointed to support commercial scale-up

EpilepsyGTx appoints Dr Teresa Nunes as Chief Medical Officer

Appointment of senior clinical leader will support progression of lead candidate EPY201 through the clinic 

FairJourney Bio announces scientific program and leadership for The Antibody Series 2026

Annual event brings together international experts in antibody discovery and development, taking place September 16–18, 2026, in Évora, Portugal

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market

EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy

ClearPoint Neuro’s system enables precise delivery to the seizure focus, ensuring best possible efficacy and safety of EpilepsyGTx’s investigational gene therapyPartnership will support first-in-human Phase 1/2a clinical trials of EPY201 in patients with focal refractor

DDW introduces new series of events aimed at connecting innovation with investment in early-stage drug discovery

Three-part event series will comprise a digital forum (30th September 2026), and two in-person events (London, UK, 4th November 2026, and Basel, Switzerland, March 2027)Focused on technology, innovation, and investment in early-stage drug discovery

Eppendorf Focuses Outreach Programmes to Advance STEM Education in Europe

Hamburg, DE, 07 JULY 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today highlights its European outreach activities dedicated to address

Bio-Rad Launches Vericheck ddPCR Kits Compatible with QX700 Platform for Biopharma Quality Control and Cell and Gene Therapy Workflows

New Vericheck ddPCR™ Kits Combine Highly Specific and Highly Sensitive DNA Detection and Quantification with the QX700™ System’s Seven-Color Multiplexing, Simplified Workflow, and Scalable Throughput

Exonate appoints Olav Hellebø as Chief Executive Officer

Appointment of experienced executive forms part of the Company’s strategy to build momentum across its proprietary platform and therapeutic programs targeting retinal diseasesCompany is preparing a Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disea

Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA

Männedorf, Switzerland, June 24, 2026: Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging 

FairJourney Bio and AbTherx Partner to Offer Fully Integrated Antibody Discovery

FairJourney Bio brings AbTherx’s Atlas transgenic mouse technologies in-house, enabling partner programmes to run from immunisation to a developability-assessed lead in one continuous workflowPartnership announced at BIO International Convention 2026, as FairJourney Bio

TRIMTECH Therapeutics brings total seed round to $47M with additional investment of $14M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio

Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc.

Pheno Therapeutics granted FDA IND clearance for lead multiple sclerosis therapeutic candidate PTD802

US FDA clearance enables first-in-human study of PTD802, a selective GPR17 antagonist Small molecule therapeutic designed to promote remyelination in neurological diseases such as multiple sclerosis Milestone supports Pheno Therapeutics’ clin

Broken String Biosciences appoints Bruce Eaton PhD as Chairman of the Board

Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution

Laverock Therapeutics reports key oncology research milestones

London, UK, 10 June 2026: Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage

PhoreMost announces lead oncology programme and appoints Chief Medical Officer to support clinical entry

Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1Comprehensive preclinical data package demonstrates differentiating oral activity and CNS penetration, unlocking treatment of primary and secondary brain cancers

Bio-Rad receives microVal validation for EZ-CheckTM Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits

Methods Certified by MicroVal for Detection of Listeria spp. and Listeria monocytogenes in Food and Environmental Samples 

Diagnostics start-up LotusDx establishes R&D laboratory at ONE BioHub to advance at-home STI testing

Dedicated R&D space to accelerate development of at-home testing to provide discreet, simple and fast solutions for sexually transmitted infectionsONE BioHub’s location and connectivity will facilitate ongoing clinical engagement with NHS Grampian and wider innovati

Laverock Therapeutics awarded in excess of £2.2M through two innovation grants to support AI-powered platform development and to expand therapeutic programmes outside of oncology

Grants totalling in excess of £2.2M awarded from two industry leading innovation fundsThe new grants will support the development of Laverock’s single-cell and AI powered gene-control platform, alongside pipeline expansion into additional therapeutic areas.

Combat Medical highlights patient impact of HIVEC HEAT trial at the American Urological Association Annual Meeting

MHRA-approved phase 3 study is investigating intravesical delivery of hyperthermic chemotherapy in bladder-sparing treatment of patients with non-muscle invasive bladder cancerStudy being conducted across 25 sites in the UK is designed to support FDA registration

SLAS celebrates innovative new products, startups and scientific excellence at European conference in Vienna

SLAS Celebrates Innovative New Products, Startups and Scientific Excellence at European Conference in Vienna 

Tecan establishes direct sales and specialist lab automation service operations in India

Strengthening local presence and customer support in a high-growth life sciences market